Altered renal function in normoalbuminuric type 2 diabetes

Renal Failure

Volumn 26, Issue 6, 2004, Pages 727-728

  Futrakul, Narisa ^a   Vongthavarawat, Varaphon ^a   Chairatanarat, Tawatchai ^a   Sirisalipotch, Sasitorn ^a   Futrakul, Prasit ^a   Suwanwalaikorn, Sompongse ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Altered renal hemodynamics; FE Mg; Type 2 diabetes

Indexed keywords

ALBUMIN; MAGNESIUM;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAGNESIUM EXCRETION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MAGNESIUM; MALE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 9644272388     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200037135     Document Type: Article

References (8)

1. Amos, A.F.; McCarthy, D.J.; Zimmet, P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 1997, 14 (Suppl. 5), S1-S85.
2. Nankervis, A.; Nicholls, K.; Kilmartin, G.; Allen, P.; Ratnaike, S.; Martin, F.I.R. Effect of perindopril on renal histomorphometry in diabetic subjects with microalbumimiria: a 3-year placebo controlled biopsy study. Metabolism 1998, 47 (Suppl. 1), 12-15.
3. Vestra, M.D.; Masicro, A.; Roiter, A.M.; Saller, A.; Crepaldi, G.; Fiorotto, P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003, 52, 1031-1035.
4. Risdon, R.A.; Sloper, J.C.; De Wardener, H.E. Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968, 1, 363-366.
5. Futrakul, P.; Yenrudi, S.; Futrakul, N.; Sensirivatana, R.; Kingwatanakul, P.; Jungthirapanich, J.; Cherdkiadtikul, T.; Laohapaibul, A.; Watana, D.; Singkhwa, V.; Futrakul, S.; Pongsin, P. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999, 33, 886-891.
6. Aaltonen, P.; Luimula, E.; Astrom, E.; et al. Change in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab. Invest. 2001, 81, 1185-1190.
7. Futrakul, N.; Tohsukhowong, P.; Patumraj, S.; Siriviriyakul, P.; Tipprukmas, N.; Futrakul, P. Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides. Ren. Fail. 2003, 25, 839-844.
8. Campbell, R.; Sangalli, F.; Perticucci, E.; Aros, C.; Viscarra, C.; Perna, A.; et al. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int. 2003, 63, 1094-1103.